Analytics, not advice. Rankings and scores describe past performance and are not recommendations.
Uncategorised
Aditya Birla Sun Life Nifty Healthcare ETF
Aditya Birla Sun Life Mutual Fund
12weak
Latest NAV
₹17.1989
as of 07 Aug 2026
AUM
—
Expense ratio
—
Inception
14 May 2026
FundScore
12/100weak
Rank #117 of 135 · top 88%
A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.
Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
3.61%
3M
8.63%
6M
18.47%
1Y
17.15%
3Y CAGR
20.22%
5Y CAGR
—
Since incep.
15.40%
NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.
Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.
Pro
Market-cap distribution
Large / mid / small / micro-cap split of this fund's equity holdings, from its latest look-through portfolio. Shown as a share of classified equity.
Large cap64.0%
Mid cap34.3%
Small cap1.7%
Stock holdings
Latest portfolio disclosure for this scheme. Snapshot as of 30 Jun 2026.
Sun Pharmaceutical Industries Limited
equity
18.13%
Apollo Hospitals Enterprise Limited
equity
8.21%
Max Healthcare Institute Limited
equity
7.73%
Divi's Laboratories Limited
equity
7.69%
Dr. Reddys Laboratories Limited
equity
7.60%
Cipla Limited
equity
7.58%
Laurus Labs Limited
equity
5.43%
Lupin Limited
equity
5.40%
Fortis Healthcare Limited
equity
4.58%
Torrent Pharmaceuticals Limited
equity
4.46%
Aurobindo Pharma Limited
equity
4.02%
Glenmark Pharmaceuticals Limited
equity
3.05%
Alkem Laboratories Limited
equity
3.00%
Biocon Limited
equity
2.74%
Mankind Pharma Ltd
equity
2.65%
Zydus Lifesciences Limited
equity
2.56%
IPCA Laboratories Limited
equity
2.17%
Abbott India Limited
equity
1.22%
Piramal Pharma Ltd
equity
0.96%
Syngene International Limited
equity
0.77%